Stock listing

GPW:PTG PolTREG Spolka Akcyjna Akcje

Follow PolTREG Spolka Akcyjna into a list and get an email when it puts out news.

Share price · GPW:PTG

17.90 PLN -0.40 (-2.2%)

Close on Nov 20, 2026

Past year -30.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
17.90 – 18.70 PLNNov 20, 2026
Volume
2,704 sharesNov 20, 2026
Market cap
105.9M PLNAt the close on Nov 20, 2026 · price × 5.92M shares outstanding
52-week range
16.00 – 29.50 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
91,899 PLNMedian day 2,828 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
PolTREG Spolka Akcyjna logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:PTG · PLN, adjusted for splits

DayCloseChange%OpenHighLowVolume
17.90-0.40-2.2%18.1518.7017.902,704
18.30-0.10-0.5%18.3519.1518.051,783
18.40-0.60-3.2%18.9518.9518.40554
19.00-0.50-2.6%18.4019.3518.40937
19.50+0.20+1.0%19.2519.5018.302,828
19.30+0.15+0.8%19.2019.3018.902,066
19.150.000.0%19.2019.2018.0015,337
19.15-0.05-0.3%19.4519.5018.006,433
19.20-0.80-4.0%20.0020.0019.006,597
20.00-0.50-2.4%20.5020.5020.001,561
20.50+0.85+4.3%19.9520.5019.601,432
19.65-1.85-8.6%21.7021.7019.657,331
21.50+0.20+0.9%21.2021.6020.003,663
21.30+0.90+4.4%20.2021.3019.806,025
20.40-0.20-1.0%20.7020.7019.257,073
20.600.000.0%20.5020.6019.801,698
20.60+0.50+2.5%19.7020.6019.501,980
20.100.000.0%20.1020.1019.351,332
20.10-0.50-2.4%20.1020.2019.80111
20.60-0.60-2.8%20.3021.0020.002,659
21.20+1.50+7.6%20.9021.2020.003,644
19.70-0.20-1.0%20.2021.2019.653,398
19.90+0.35+1.8%19.1520.2019.153,356
19.55+0.55+2.9%19.7019.7019.10180
19.00-0.55-2.8%20.0020.0019.003,072
19.55-0.95-4.6%20.2020.4019.55252
20.50+0.75+3.8%19.8020.5019.152,617
19.75+0.25+1.3%19.0019.7519.00539
19.50-0.05-0.3%20.1020.2019.0012,094
19.55-0.45-2.2%20.0020.2019.552,015
20.00-0.30-1.5%19.6520.2019.65807
20.30-0.10-0.5%20.3020.3019.901,107
20.40+0.10+0.5%20.0020.4019.202,474
20.30-0.10-0.5%20.4020.4020.001,287
20.40-0.10-0.5%19.8020.7019.604,187
20.50-0.40-1.9%21.1021.2019.9510,393
20.90-0.80-3.7%21.6021.6020.008,180
21.70+0.40+1.9%21.5021.7020.005,955
21.30+0.60+2.9%20.8021.3020.502,176
20.70+0.60+3.0%20.1020.7019.652,511
20.10-0.20-1.0%20.0020.2019.108,574
20.30-0.20-1.0%20.0020.7019.801,566
20.50-0.50-2.4%20.2021.1019.958,387
21.000.000.0%20.5021.4020.102,206
21.00-0.70-3.2%21.4021.7019.7013,345
21.70-0.20-0.9%22.0022.0021.501,078
21.90-1.00-4.4%22.9023.0021.904,366
22.90+0.10+0.4%22.2022.9021.203,669
22.80+0.40+1.8%22.3022.8022.001,453
22.40+0.10+0.4%22.3022.4022.101,118
22.30-0.90-3.9%23.2023.2022.104,311
23.20+1.00+4.5%22.7023.2022.104,316
22.20+0.30+1.4%22.3023.4022.208,419
21.90-0.20-0.9%22.2022.3021.90648
22.10-1.00-4.3%23.1023.1021.806,720
23.10+0.40+1.8%22.7023.3022.103,019
22.70-0.80-3.4%23.5023.5022.006,215
23.50-0.10-0.4%23.0023.6022.702,664
23.600.000.0%23.0023.6023.002,903
23.60-0.10-0.4%23.2024.2022.804,667
23.70-1.30-5.2%24.7024.7022.5019,983
25.00-0.20-0.8%25.0025.5024.0012,502
25.20-1.40-5.3%26.4026.7024.509,828
26.60+0.10+0.4%26.5026.7025.601,685
26.50+0.90+3.5%25.6026.5025.301,523
Ticker
GPW:PTG
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
GPW
Currency
PLN

What changed lately

Latest news

All PolTREG Spolka Akcyjna news

PolTREG Spolka Akcyjna on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 15 in all · newest Mar 10, 2026 · oldest 2024
Decks
15 decks · latest February 2026

Valuation

EV/sales 378× against a median of −13.9×: the highest of 3 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
90.74M PLN
P/E
Loss
EV/sales
378×
EV/EBITDA
Negative EBITDA
Price/book
2.2×
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.1×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PolTREG Spolka Akcyjna · GPW:PTGUS$26.09MUS$22.35Mn/a378×n/a2.2×n/a0.1×n/a
Edesa Biotech, Inc. · NASDAQ:EDSAUS$27.02MUS$16.72Mn/an/an/a3.1×n/a0.0×0.47
Amplia Therapeutics Ltd. · ASX:ATXUS$26.84MUS$8.63Mn/an/an/a1.0×n/a0.0×n/a
Nasus Pharma Ltd. · AMEX:NSRXUS$26.82MUS$15.11Mn/an/an/a2.4×n/a0.0×0.99
Telomir Pharmaceuticals, Inc. · NASDAQ:TELOUS$26.82MUS$22.30Mn/an/an/a6.1×n/a0.0×1.74
BriaCell Therapeutics Corp · TSX:BCTUS$26.79MUS$6.25Mn/an/an/a1.7×n/a0.0×1.07
Alterity Therapeutics Ltd. · ASX:ATHUS$26.76MUS$2.18Mn/an/an/a0.9×n/a0.0×n/a
EyePoint, Inc. · NASDAQ:EYPTUS$26.65M−US$72.44Mn/a−28.1×n/a0.3×n/a0.2×1.36
Aprogen, Inc · KRX:007460US$26.64MUS$21.31Mn/a0.2×n/a0.6×−60.1%0.6×n/a
Launxp Biomedical Co., Ltd. · TPEX:6876US$25.67MUS$11.86Mn/an/an/a2.3×n/a0.0×n/a
INmune Bio Inc. · NASDAQ:INMBUS$25.60MUS$10.48Mn/an/an/a1.4×n/a0.1×2.63
Median of the othersUS$26.77MUS$11.17M−13.9×1.6×−60.1%0.0×1.22

Forecasts

Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.

Price target
29.30 PLN · Analysts' mean
EPS, year to Dec 2026
-5.50 · 1 analyst
Revenue, year to Dec 2026
800K · 1 analyst

Team and board

OfficerRole
Piotr TrzonkowskiChief Executive Officer
Dan ShellyChief Business Development Officer

Events

QuarterResultsShare move
Q2 2026Sep 10, 2026+2.2%
Q1 2026May 21, 2026+2.3%
Q3 2025Dec 3, 2025−9.4%
Q2 2025Sep 3, 2025−5.7%
Q1 2025May 28, 2025−3.4%
Q3 2024Nov 27, 2024−4.5%
Q2 2024Sep 12, 2024 · After close−2.3%
Q1 2024May 23, 2024 · After close−0.2%
Q4 2023Feb 28, 2024+2.3%
Q3 2023Nov 29, 2023−1.9%
All 15 quarters
QuarterResultsShare move
Q2 2023Aug 30, 2023−3.8%
Q1 2023May 31, 2023−2.9%
Q4 2022Mar 1, 2023+2.6%
Q3 2022Nov 30, 2022+2.1%
Q1 2022Apr 29, 2022 · After close+1.9%

Open Events

Decks

DeckKindSlidesDate
PolTREG — Investor Presentation (February 2026)Investor deck33 slidesFebruary 2026
PolTREG — Investor Presentation (September 2024)Investor deck30 slidesSep 13, 2024
PolTREG — Investor Presentation (March 2024)Investor deck23 slidesMar 7, 2024
PolTREG — Investor Presentation (February 2024)Investor deck28 slidesFeb 26, 2024
PolTREG — Investor Presentation (January 2024)Investor deck23 slidesJan 30, 2024
PolTREG — Investor Presentation (December 2023)Investor deck28 slidesDec 19, 2023
PolTREG — Q3 2023 Earnings PresentationEarnings21 slidesNov 23, 2023
PolTREG — Corporate Update (June 2023)Corporate update65 slidesJun 19, 2023
PolTREG — Investor Presentation (April 2023)Investor deck21 slidesApril 2023
PolTREG — Investor Presentation (January 2023)Investor deck26 slidesJanuary 2023
All 15 decks
DeckKindSlidesDate
PolTREG — Investor Presentation (December 2022)Investor deck27 slidesDec 6, 2022
PolTREG — Q3 2022 Earnings PresentationEarnings35 slidesNov 28, 2022
PolTREG — Trigon Tech Conference 2022Conference26 slidesSeptember 2022
PolTREG — Investor Presentation (May 2022)Investor deck34 slidesMay 2022
PolTREG — Investor Presentation (December 2021)Investor deck28 slidesDecember 2021

Open Decks

Financials

Annual, in PLN

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue0350.0K1.40M999.0K1.10M700.0K500.0K0
Cost of revenue5.66M4.79M2.79M1.12M282.0K243.0K278.0K105.0K
Gross profit-5.66M-4.45M-1.39M-124.0K817.0K457.0K222.0K-105.0K
Selling, general and administrative4.79M3.59M3.96M3.50M2.47M1.20M816.0K543.0K
Operating income-35.5M-20.3M-16.9M-5.23M-3.48M-955.0K-680.0K-1.26M
Depreciation and amortization5.66M4.01M1.05M823.0K575.0K557.0K567.0K310.0K
EBITDA-29.9M-16.3M-15.8M-4.41M-2.90M-398.0K-113.0K-950.0K
Interest expense929.0K837.0K356.0K301.0K41.0K104.0K198.0K249.0K
Income before tax-26.0M-18.7M-13.6M-1.97M-3.74M-878.0K-967.0K-1.35M
Income tax-3.27M41.0K198.0K
Net income-26.0M-18.7M-13.6M-1.97M-3.74M-878.0K-967.0K-1.35M
Earnings per share, basic-5.58-4.01-2.91-0.42-1.09-0.26-0.29-0.41

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents17.8M45.7M66.0M90.0M103.9M15.1M5.17M7.91M
Receivables4.64M1.70M5.58M9.33M795.0K253.0K126.0K28.0K
Inventory1.16M727.0K415.0K83.0K05.00K00
Current assets23.6M48.1M72.0M99.5M106.0M15.6M5.63M9.05M
Property, plant and equipment22.8M2.08M656.0K1.21M1.42M
Total assets73.0M102.4M127.1M123.3M109.1M16.2M6.84M10.5M
Accounts payable1.12M856.0K1.25M862.0K294.0K56.0K393.0K245.0K
Current liabilities10.1M11.5M18.5M13.8M5.68M3.00M4.34M2.46M
Long-term debt09.00K294.0K406.0K2.61M
Total debt7.62M7.97M8.19M7.90M178.0K763.0K2.04M4.07M
Total liabilities17.2M33.1M39.6M22.3M6.12M3.41M6.85M9.70M
Shareholders' equity43.3M69.2M87.5M101.0M103.0M12.8M-6.00K764.0K
Shares outstanding4.66M4.66M4.66M4.66M3.42M3.33M3.33M3.33M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-28.7M-16.0M-13.3M-8.60M-3.84M-2.79M-1.19M-1.04M
Capital spending-543.0K-8.75M-31.6M-7.58M-2.97M-2.97M-421.0K-103.0K
Free cash flow-29.2M-25.6M-44.9M-16.2M-6.80M-2.79M-1.61M-1.15M
Cash from investing-547.0K-8.75M-31.6M-5.05M-454.0K362.0K417.0K4.72M
Cash from financing1.35M4.46M20.8M2.28M93.2M12.3M-1.96M-47.0K
Change in cash-27.9M-20.3M-24.1M-13.9M88.9M9.88M-2.73M3.63M

Open Financials

Cap table

Built by 6ix from PolTREG Spolka Akcyjna’s releases

Common shares
5,916,456
Fully diluted
5,916,456

Fully diluted

LineShares
Common shares5,916,456

Share count over time

CountShares
Nov 22, 20265,916,456

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dan ShellyChief Business Development Officer · Since at least Jun 13, 2025
Piotr TrzonkowskiChief Executive Officer · Since at least Mar 10, 2026

Open People

Log in to ask 6ix AI your own questions about PolTREG Spolka Akcyjna.